{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:32:17Z","timestamp":1790087537806,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000837","name":"University of Nottingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000840","name":"Anaesthetics Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["VIA 061"],"award-info":[{"award-number":["VIA 061"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["IIS-2018-106697"],"award-info":[{"award-number":["IIS-2018-106697"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:18:47Z","timestamp":1715674727000},"page":"967-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Impact of extended Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the gut microbiome in cystic fibrosis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-1721","authenticated-orcid":false,"given":"Ryan","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0144-4327","authenticated-orcid":false,"given":"Claudio Dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-2673","authenticated-orcid":false,"given":"Alexander","family":"Yule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-1684","authenticated-orcid":false,"given":"Neele S","family":"Dellschaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-1027","authenticated-orcid":false,"given":"Caroline L","family":"Hoad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7243-3014","authenticated-orcid":false,"given":"Christabella","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7944-3709","authenticated-orcid":false,"given":"Giles","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Rivett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-4048","authenticated-orcid":false,"given":"Christopher","family":"van der Gast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.05.002_bib0001","article-title":"How can we Relieve Gastrointestinal Symptoms in people with Cystic Fibrosis? An International Qualitative Survey","volume":"7","author":"Smith","year":"2020"},{"key":"10.1016\/j.jcf.2024.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"The Changing Face of Cystic Fibrosis in the Era of Precision Medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0003","unstructured":"Cystic Fibrosis Trust, UK Cystic Fibrosis Trust, UK Cystic Fibrosis Registry. 2022 Annual Data Report, London, 2023."},{"key":"10.1016\/j.jcf.2024.05.002_bib0004","unstructured":"Cystic Fibrosis Refresh Top 10 priorities (priority setting in association with the JLA), (2022). https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/cystic-fibrosis-refresh\/top-10-priorities.htm."},{"key":"10.1016\/j.jcf.2024.05.002_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thorax-2023-220100","article-title":"A Refresh of the Top 10 Research Priorities in Cystic Fibrosis","volume":"78","author":"Rowbotham","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.05.002_bib0006","article-title":"Serial Analysis of the Gut and Respiratory Microbiome","volume":"3","author":"Madan","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.jcf.2024.05.002_bib0007","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut Microbiota in Children With Cystic Fibrosis: a Taxonomic and Functional Dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.05.002_bib0008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The Altered Gut Microbiota in Adults with Cystic Fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the Gut Microbiota in Early Life: the Impact of Cystic Fibrosis and Antibiotic Treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0010","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep4.1266","article-title":"Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice","volume":"2","author":"Debray","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcf.2024.05.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008251","article-title":"CFTR Dysregulation Drives Active Selection of the Gut Microbiome","volume":"16","author":"Meeker","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcf.2024.05.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198457","article-title":"Altered Intestinal Microbiota Composition, Antibiotic Therapy and Intestinal Inflammation in Children and Adolescents with Cystic Fibrosis","volume":"13","author":"De Freitas","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.05.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116967","article-title":"Intestinal Lesions are Associated with Altered Intestinal Microbiome and are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis","volume":"10","author":"Flass","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.05.002_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13073-020-0710-2","article-title":"Interactions Between the Gut Microbiome and Host Gene Regulation in Cystic Fibrosis","volume":"12","author":"Dayama","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jcf.2024.05.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR Modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.05.002_bib0016","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcf.2022.06.002","article-title":"Modulation, Microbiota and Inflammation in the adult CF Gut: a Prospective Study","volume":"21","author":"Ronan","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0017","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jcf.2020.12.002","article-title":"Changes in Fecal Microbiota with CFTR Modulator Therapy: a Pilot Study","volume":"20","author":"Pope","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/jpm11050350","article-title":"Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a s1251n Mutation","volume":"11","author":"Kristensen","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2024.05.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01175-23","article-title":"Tezacaftor\/Ivacaftor Therapy has Negligible Effects on the Cystic Fibrosis Gut Microbiome","volume":"11","author":"Marsh","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcf.2024.05.002_bib0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/MPG.0000000000002864","article-title":"Reduced Intestinal Inflammation With Lumacaftor\/Ivacaftor in Adolescents With Cystic Fibrosis","volume":"71","author":"Tetard","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2024.05.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.05.002_bib0022","first-page":"e29359","article-title":"Newly Discovered Cutting-Edge Triple Combination Cystic Fibrosis Therapy: a Systematic Review","volume":"14","author":"Dawood","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2024.05.002_bib0023","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcf.2020.06.004","article-title":"Postprandial Changes in Gastrointestinal Function and Transit in Cystic Fibrosis Assessed by Magnetic Resonance Imaging","volume":"20","author":"Ng","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0024","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal Function and Transit Associate with Gut Microbiota Dysbiosis in Cystic Fibrosis","volume":"21","author":"Marsh","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0025","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1088\/0031-9155\/52\/23\/009","article-title":"Non-invasive Quantification of Small Bowel Water Content by MRI: a Validation Study","volume":"52","author":"Hoad","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0026","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1651-2227.2011.02580.x","article-title":"Estimation of Body Surface Area in Various Childhood Ages\u2013Validation of the Mosteller Formula","volume":"101","author":"El Edelbi","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2024.05.002_bib0027","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric Validation of a Constipation Symptom Assessment Questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134802","article-title":"Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool","volume":"10","author":"Gorzelak","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.05.002_bib0029","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/ismej.2012.145","article-title":"Reducing Bias in Bacterial Community Analysis of Lower Respiratory Infections","volume":"7","author":"Rogers","year":"2013","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2024.05.002_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high Resolution Sample Inference from Illumina Amplicon Data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcf.2024.05.002_bib0031","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-018-0605-2","article-title":"Simple Statistical Identification and Removal of Contaminant Sequences in Marker-Gene and Metagenomics Data","volume":"6","author":"Davis","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.jcf.2024.05.002_bib0032","first-page":"9","article-title":"PAST: paleontological Statistics Software Package for Education and Data Analysis","volume":"4","author":"Hammer","year":"2001","journal-title":"Palaeontol Electron"},{"key":"10.1016\/j.jcf.2024.05.002_bib0033","series-title":"CANOCO reference manual and user's guide: software for ordination","author":"ter Braak","year":"2012"},{"key":"10.1016\/j.jcf.2024.05.002_bib0034","doi-asserted-by":"crossref","first-page":"fiw230","DOI":"10.1093\/femsec\/fiw230","article-title":"Impact of Cystic Fibrosis Disease on Archaea and Bacteria Composition of Gut Microbiota","volume":"93","author":"Miragoli","year":"2017","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0035","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1038\/srep22493","article-title":"Metagenomic Evidence for Taxonomic Dysbiosis and Functional Imbalance in the Gastrointestinal Tracts of Children with Cystic Fibrosis","volume":"6","author":"Manor","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.05.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1099\/ijsem.0.005379","article-title":"Genome-Based, Phenotypic and Chemotaxonomic Classification of Faecalibacterium Strains: proposal of Three Novel Species Faecalibacterium duncaniae sp. nov., Faecalibacterium hattorii sp. nov. and Faecalibacterium gallinarum sp","volume":"72","author":"Sakamoto","year":"2022","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0037","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0038","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcf.2023.01.013","article-title":"The Gut Microbiome, Short Chain Fatty Acids, and Related Metabolites in Cystic Fibrosis Patients with and without Colonic Adenomas","volume":"22","author":"Baldwin-Hunter","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/19490976.2018.1534512","article-title":"Opportunistic Bacteria Confer the Ability to Ferment Prebiotic Starch in the Adult Cystic Fibrosis Gut","volume":"10","author":"Wang","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jcf.2024.05.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208171","article-title":"Gut Microbiota Signatures in Cystic Fibrosis: loss of Host CFTR Function Drives the Microbiota Enterophenotype","volume":"13","author":"Vernocchi","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.05.002_bib0041","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/gutjnl-2013-306423","article-title":"Faecal Metabolite Profiling Identifies Medium-Chain Fatty Acids as Discriminating Compounds in IBD","volume":"64","author":"De Preter","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2024.05.002_bib0042","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","article-title":"Dysbiosis of Bifidobacteria and Clostridium Cluster XIVa in the Cystic Fibrosis Fecal Microbiota","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0043","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/jcm8050645","article-title":"Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances","volume":"8","author":"Enaud","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2024.05.002_bib0044","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/thoraxjnl-2020-216265","article-title":"Projecting the Impact of Triple CFTR Modulator Therapy on Intravenous Antibiotic Requirements in Cystic Fibrosis using Patient Registry Data Combined with Treatment Effects from Randomised Trials","volume":"77","author":"Keogh","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.05.002_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/apt.16673","article-title":"Small Bowel Water Content Assessed by MRI in Health and Disease: a Collation of Single-Centre Studies","volume":"55","author":"Dellschaft","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2024.05.002_bib0046","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial Overgrowth, Dysbiosis, Inflammation, and Dysmotility in the Cystic Fibrosis Intestine","volume":"16","author":"Dorsey","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0047","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcf.2023.06.010","article-title":"Body Mass Index and Nutritional Intake Following Elexacaftor\/Tezacaftor\/Ivacaftor Modulator Therapy in Adults with Cystic Fibrosis","volume":"22","author":"Caley","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0048","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","article-title":"Bifidobacteria and Butyrate-Producing Colon Bacteria: importance and Strategies for their Stimulation in the Human Gut","volume":"7","author":"Rivi\u00e8re","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0049","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a Member of the Human Gut Microbiome Associated with Crohn's Disease, Produces an Inflammatory Polysaccharide","volume":"116","author":"Henke","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2024.05.002_bib0050","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/s41598-017-06880-y","article-title":"A Pilot Study Demonstrating the Altered Gut Microbiota Functionality in Stable Adults with Cystic Fibrosis","volume":"7","author":"Fouhy","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.05.002_bib0051","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jcf.2020.11.009","article-title":"The Cystic Fibrosis Gut as a Potential Source of Multidrug Resistant Pathogens","volume":"20","author":"Taylor","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0052","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/microorganisms11010009","article-title":"Gut Dysbiosis in Children with Cystic Fibrosis: development, Features and the Role of Gut-Lung Axis on Disease Progression","volume":"11","author":"Testa","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jcf.2024.05.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations Between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.05.002_bib0054","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cit715","article-title":"Escherichia coli Dysbiosis Correlates with Gastrointestinal Dysfunction in Children with Cystic Fibrosis","volume":"58","author":"Hoffman","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2024.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1073\/pnas.1714373115","article-title":"Adaptation of Commensal Proliferating Escherichia coli to the Intestinal Tract of Young Children with Cystic Fibrosis","volume":"115","author":"Matamouros","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2024.05.002_bib0056","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fmicb.2016.01204","article-title":"Gut Bifidobacteria Populations in Human Health and Aging","volume":"7","author":"Arboleya","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0057","article-title":"Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score","volume":"14","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0058","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2014.02.005","article-title":"Cystic Fibrosis: evidence for Gut Inflammation","volume":"52","author":"Munck","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0059","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.3390\/jcm9124080","article-title":"Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis","volume":"9","author":"Beaufils","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2024.05.002_bib0061","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor and Gastrointestinal Outcomes in Cystic Fibrosis: report of Promise-GI","volume":"22","author":"Schwarzenberg","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.05.002_bib0062","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ismej.2010.175","article-title":"Partitioning Core and Satellite Taxa From within Cystic Fibrosis Lung Bacterial Communities","volume":"5","author":"van der Gast","year":"2011","journal-title":"ISME J"},{"key":"10.1016\/j.jcf.2024.05.002_bib0063","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1461-0248.2007.01024.x","article-title":"Species Abundance Distributions Over Time","volume":"10","author":"Magurran","year":"2007","journal-title":"Ecol Lett"},{"key":"10.1016\/j.jcf.2024.05.002_bib0064","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic Fibrosis-Related Gut Dysbiosis: a Systematic Review","volume":"68","author":"Caley","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2024.05.002_bib0065","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3390\/nu14153160","article-title":"Probiotics Administration in Cystic Fibrosis: what Is the Evidence?","volume":"14","author":"Esposito","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2024.05.002_bib0066","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2156254","article-title":"Diet and the gut-lung axis in cystic fibrosis - direct & indirect links","volume":"15","author":"McKay","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jcf.2024.05.002_bib0067","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12866-023-02788-y","article-title":"Resilience and Stability of the CF- Intestinal and Respiratory Microbiome during Nutritional and Exercise Intervention","volume":"23","author":"Knoll","year":"2023","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcf.2024.05.002_bib0068","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.05.002_bib0069","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S2213-2600(23)00324-7","article-title":"Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy","volume":"11","author":"Hisert","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.05.002_bib0070","article-title":"Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: current Approaches and Exploring Future Directions","volume":"12","author":"O'Toole","year":"2021","journal-title":"MBio"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:13:27Z","timestamp":1788246807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932400064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S156919932400064X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.05.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.01.24301982","asserted-by":"object"}]},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of extended Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the gut microbiome in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}